nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—CYP3A4—breast cancer	0.204	1	CbGaD
Alimemazine—Dextropropoxyphene—Toremifene—breast cancer	0.0487	0.12	CrCrCtD
Alimemazine—CYP3A4—Exemestane—breast cancer	0.0407	0.133	CbGbCtD
Alimemazine—Clofedanol—Toremifene—breast cancer	0.0352	0.0869	CrCrCtD
Alimemazine—Cyclobenzaprine—Tamoxifen—breast cancer	0.0351	0.0865	CrCrCtD
Alimemazine—CYP3A4—Letrozole—breast cancer	0.0346	0.113	CbGbCtD
Alimemazine—Orphenadrine—Toremifene—breast cancer	0.0341	0.0841	CrCrCtD
Alimemazine—Benzphetamine—Toremifene—breast cancer	0.0341	0.0841	CrCrCtD
Alimemazine—CYP3A4—Anastrozole—breast cancer	0.0308	0.101	CbGbCtD
Alimemazine—Dextropropoxyphene—Tamoxifen—breast cancer	0.0306	0.0755	CrCrCtD
Alimemazine—Diphenhydramine—Toremifene—breast cancer	0.0303	0.0747	CrCrCtD
Alimemazine—CYP3A4—Toremifene—breast cancer	0.0282	0.0921	CbGbCtD
Alimemazine—Dimetacrine—Tamoxifen—breast cancer	0.0272	0.0672	CrCrCtD
Alimemazine—CYP3A4—Fulvestrant—breast cancer	0.0262	0.0856	CbGbCtD
Alimemazine—Methadone—Tamoxifen—breast cancer	0.0256	0.0632	CrCrCtD
Alimemazine—CYP3A4—Thiotepa—breast cancer	0.0234	0.0763	CbGbCtD
Alimemazine—Clofedanol—Tamoxifen—breast cancer	0.0221	0.0546	CrCrCtD
Alimemazine—Orphenadrine—Tamoxifen—breast cancer	0.0214	0.0528	CrCrCtD
Alimemazine—Benzphetamine—Tamoxifen—breast cancer	0.0214	0.0528	CrCrCtD
Alimemazine—CYP3A4—Ixabepilone—breast cancer	0.0214	0.0698	CbGbCtD
Alimemazine—CYP3A4—Lapatinib—breast cancer	0.0206	0.0672	CbGbCtD
Alimemazine—Promazine—Tamoxifen—breast cancer	0.0204	0.0504	CrCrCtD
Alimemazine—Diphenhydramine—Tamoxifen—breast cancer	0.019	0.0469	CrCrCtD
Alimemazine—CYP3A4—Raloxifene—breast cancer	0.0156	0.0509	CbGbCtD
Alimemazine—CYP3A4—Vinorelbine—breast cancer	0.0114	0.0373	CbGbCtD
Alimemazine—CYP3A4—Tamoxifen—breast cancer	0.0103	0.0336	CbGbCtD
Alimemazine—CYP3A4—Mitoxantrone—breast cancer	0.0101	0.0328	CbGbCtD
Alimemazine—CYP3A4—Paclitaxel—breast cancer	0.00802	0.0262	CbGbCtD
Alimemazine—CYP3A4—Irinotecan—breast cancer	0.00791	0.0258	CbGbCtD
Alimemazine—CYP3A4—Vinblastine—breast cancer	0.00703	0.023	CbGbCtD
Alimemazine—CYP3A4—Docetaxel—breast cancer	0.0058	0.0189	CbGbCtD
Alimemazine—CYP3A4—Doxorubicin—breast cancer	0.00432	0.0141	CbGbCtD
Alimemazine—Trifluoperazine—S100A4—breast cancer	0.000461	0.141	CrCbGaD
Alimemazine—Dimetacrine—ACHE—breast cancer	0.000317	0.0969	CrCbGaD
Alimemazine—Nervous system disorder—Ixabepilone—breast cancer	0.000303	0.004	CcSEcCtD
Alimemazine—Agranulocytosis—Vinblastine—breast cancer	0.0003	0.00396	CcSEcCtD
Alimemazine—Body temperature increased—Fulvestrant—breast cancer	0.000298	0.00393	CcSEcCtD
Alimemazine—Jaundice—Melphalan—breast cancer	0.000298	0.00393	CcSEcCtD
Alimemazine—Dry mouth—Anastrozole—breast cancer	0.000297	0.00392	CcSEcCtD
Alimemazine—Dry mouth—Letrozole—breast cancer	0.000297	0.00392	CcSEcCtD
Alimemazine—Insomnia—Exemestane—breast cancer	0.000296	0.00391	CcSEcCtD
Alimemazine—Convulsion—Idarubicin—breast cancer	0.000293	0.00387	CcSEcCtD
Alimemazine—Jaundice—Goserelin—breast cancer	0.000291	0.00384	CcSEcCtD
Alimemazine—Infection—Letrozole—breast cancer	0.000289	0.00382	CcSEcCtD
Alimemazine—Infection—Anastrozole—breast cancer	0.000289	0.00382	CcSEcCtD
Alimemazine—Hypotension—Ixabepilone—breast cancer	0.000289	0.00381	CcSEcCtD
Alimemazine—Nervous system disorder—Letrozole—breast cancer	0.000285	0.00377	CcSEcCtD
Alimemazine—Insomnia—Ixabepilone—breast cancer	0.000279	0.00369	CcSEcCtD
Alimemazine—Infection—Raloxifene—breast cancer	0.000274	0.00362	CcSEcCtD
Alimemazine—Infection—Idarubicin—breast cancer	0.000274	0.00362	CcSEcCtD
Alimemazine—Nervous system disorder—Raloxifene—breast cancer	0.000271	0.00357	CcSEcCtD
Alimemazine—Insomnia—Anastrozole—breast cancer	0.000263	0.00347	CcSEcCtD
Alimemazine—Insomnia—Letrozole—breast cancer	0.000263	0.00347	CcSEcCtD
Alimemazine—Orthostatic hypotension—Irinotecan—breast cancer	0.000261	0.00345	CcSEcCtD
Alimemazine—Hypokalaemia—Mitoxantrone—breast cancer	0.00026	0.00343	CcSEcCtD
Alimemazine—Hypokalaemia—Irinotecan—breast cancer	0.00026	0.00343	CcSEcCtD
Alimemazine—Body temperature increased—Exemestane—breast cancer	0.000259	0.00342	CcSEcCtD
Alimemazine—Rash—Lapatinib—breast cancer	0.000258	0.00341	CcSEcCtD
Alimemazine—Dermatitis—Lapatinib—breast cancer	0.000258	0.00341	CcSEcCtD
Alimemazine—Tremor—Chlorambucil—breast cancer	0.000257	0.00339	CcSEcCtD
Alimemazine—Nasal congestion—Paclitaxel—breast cancer	0.000256	0.00338	CcSEcCtD
Alimemazine—Hypokalaemia—Gemcitabine—breast cancer	0.000253	0.00334	CcSEcCtD
Alimemazine—Agitation—Chlorambucil—breast cancer	0.000252	0.00332	CcSEcCtD
Alimemazine—Arrhythmia—Tamoxifen—breast cancer	0.00025	0.0033	CcSEcCtD
Alimemazine—Insomnia—Raloxifene—breast cancer	0.00025	0.0033	CcSEcCtD
Alimemazine—Agranulocytosis—Vinorelbine—breast cancer	0.000249	0.00329	CcSEcCtD
Alimemazine—Jaundice—Thiotepa—breast cancer	0.000249	0.00328	CcSEcCtD
Alimemazine—Cardiac disorder—Goserelin—breast cancer	0.000248	0.00328	CcSEcCtD
Alimemazine—Arrhythmia—Melphalan—breast cancer	0.000245	0.00324	CcSEcCtD
Alimemazine—Body temperature increased—Ixabepilone—breast cancer	0.000244	0.00322	CcSEcCtD
Alimemazine—Arrhythmia—Goserelin—breast cancer	0.000239	0.00316	CcSEcCtD
Alimemazine—Agranulocytosis—Thiotepa—breast cancer	0.000238	0.00314	CcSEcCtD
Alimemazine—Rash—Fulvestrant—breast cancer	0.000238	0.00314	CcSEcCtD
Alimemazine—Dermatitis—Fulvestrant—breast cancer	0.000237	0.00313	CcSEcCtD
Alimemazine—Convulsion—Chlorambucil—breast cancer	0.000237	0.00313	CcSEcCtD
Alimemazine—Rash—Toremifene—breast cancer	0.000235	0.0031	CcSEcCtD
Alimemazine—Dermatitis—Toremifene—breast cancer	0.000234	0.00309	CcSEcCtD
Alimemazine—Eosinophilia—Fluorouracil—breast cancer	0.000234	0.00309	CcSEcCtD
Alimemazine—Body temperature increased—Letrozole—breast cancer	0.00023	0.00304	CcSEcCtD
Alimemazine—Body temperature increased—Anastrozole—breast cancer	0.00023	0.00304	CcSEcCtD
Alimemazine—Erectile dysfunction—Mitoxantrone—breast cancer	0.000227	0.003	CcSEcCtD
Alimemazine—Cardiac disorder—Vinorelbine—breast cancer	0.000222	0.00294	CcSEcCtD
Alimemazine—Infection—Chlorambucil—breast cancer	0.000222	0.00293	CcSEcCtD
Alimemazine—Body temperature increased—Idarubicin—breast cancer	0.000218	0.00288	CcSEcCtD
Alimemazine—Body temperature increased—Raloxifene—breast cancer	0.000218	0.00288	CcSEcCtD
Alimemazine—Photosensitivity—Capecitabine—breast cancer	0.000218	0.00288	CcSEcCtD
Alimemazine—Convulsion—Vinblastine—breast cancer	0.000218	0.00287	CcSEcCtD
Alimemazine—Photosensitivity reaction—Fluorouracil—breast cancer	0.000216	0.00285	CcSEcCtD
Alimemazine—Jaundice—Irinotecan—breast cancer	0.000215	0.00283	CcSEcCtD
Alimemazine—Jaundice—Mitoxantrone—breast cancer	0.000215	0.00283	CcSEcCtD
Alimemazine—Arrhythmia—Vinorelbine—breast cancer	0.000214	0.00283	CcSEcCtD
Alimemazine—Orthostatic hypotension—Paclitaxel—breast cancer	0.000213	0.00281	CcSEcCtD
Alimemazine—Cardiac disorder—Thiotepa—breast cancer	0.000212	0.0028	CcSEcCtD
Alimemazine—Hypokalaemia—Paclitaxel—breast cancer	0.000212	0.0028	CcSEcCtD
Alimemazine—Amenorrhoea—Epirubicin—breast cancer	0.000209	0.00276	CcSEcCtD
Alimemazine—Jaundice cholestatic—Epirubicin—breast cancer	0.000209	0.00276	CcSEcCtD
Alimemazine—Convulsion—Melphalan—breast cancer	0.000207	0.00273	CcSEcCtD
Alimemazine—Rash—Exemestane—breast cancer	0.000206	0.00273	CcSEcCtD
Alimemazine—Dermatitis—Exemestane—breast cancer	0.000206	0.00272	CcSEcCtD
Alimemazine—Agranulocytosis—Mitoxantrone—breast cancer	0.000205	0.00271	CcSEcCtD
Alimemazine—Arrhythmia—Thiotepa—breast cancer	0.000204	0.0027	CcSEcCtD
Alimemazine—Dry mouth—Tamoxifen—breast cancer	0.000203	0.00268	CcSEcCtD
Alimemazine—Convulsion—Goserelin—breast cancer	0.000202	0.00266	CcSEcCtD
Alimemazine—Agranulocytosis—Gemcitabine—breast cancer	0.0002	0.00264	CcSEcCtD
Alimemazine—Infection—Tamoxifen—breast cancer	0.000198	0.00261	CcSEcCtD
Alimemazine—Agranulocytosis—Fluorouracil—breast cancer	0.000197	0.0026	CcSEcCtD
Alimemazine—Dyskinesia—Epirubicin—breast cancer	0.000195	0.00258	CcSEcCtD
Alimemazine—Rash—Ixabepilone—breast cancer	0.000195	0.00257	CcSEcCtD
Alimemazine—Dermatitis—Ixabepilone—breast cancer	0.000195	0.00257	CcSEcCtD
Alimemazine—Dry mouth—Goserelin—breast cancer	0.000194	0.00256	CcSEcCtD
Alimemazine—Infection—Melphalan—breast cancer	0.000194	0.00256	CcSEcCtD
Alimemazine—Jaundice cholestatic—Doxorubicin—breast cancer	0.000193	0.00255	CcSEcCtD
Alimemazine—Amenorrhoea—Doxorubicin—breast cancer	0.000193	0.00255	CcSEcCtD
Alimemazine—Atrioventricular block—Epirubicin—breast cancer	0.000189	0.0025	CcSEcCtD
Alimemazine—Infection—Goserelin—breast cancer	0.000189	0.00249	CcSEcCtD
Alimemazine—Nervous system disorder—Goserelin—breast cancer	0.000186	0.00246	CcSEcCtD
Alimemazine—Photosensitivity reaction—Paclitaxel—breast cancer	0.000184	0.00243	CcSEcCtD
Alimemazine—Ventricular tachycardia—Epirubicin—breast cancer	0.000184	0.00242	CcSEcCtD
Alimemazine—Cardiac disorder—Irinotecan—breast cancer	0.000183	0.00242	CcSEcCtD
Alimemazine—Rash—Anastrozole—breast cancer	0.000183	0.00242	CcSEcCtD
Alimemazine—Rash—Letrozole—breast cancer	0.000183	0.00242	CcSEcCtD
Alimemazine—Dermatitis—Letrozole—breast cancer	0.000183	0.00242	CcSEcCtD
Alimemazine—Dermatitis—Anastrozole—breast cancer	0.000183	0.00242	CcSEcCtD
Alimemazine—Agitation—Thiotepa—breast cancer	0.000183	0.00242	CcSEcCtD
Alimemazine—Hypotension—Melphalan—breast cancer	0.000182	0.0024	CcSEcCtD
Alimemazine—Dyskinesia—Doxorubicin—breast cancer	0.000181	0.00239	CcSEcCtD
Alimemazine—Orthostatic hypotension—Docetaxel—breast cancer	0.00018	0.00238	CcSEcCtD
Alimemazine—Insomnia—Tamoxifen—breast cancer	0.00018	0.00238	CcSEcCtD
Alimemazine—Cardiac disorder—Gemcitabine—breast cancer	0.000179	0.00236	CcSEcCtD
Alimemazine—Hypotension—Goserelin—breast cancer	0.000178	0.00235	CcSEcCtD
Alimemazine—Body temperature increased—Chlorambucil—breast cancer	0.000177	0.00233	CcSEcCtD
Alimemazine—Arrhythmia—Mitoxantrone—breast cancer	0.000177	0.00233	CcSEcCtD
Alimemazine—Arrhythmia—Irinotecan—breast cancer	0.000177	0.00233	CcSEcCtD
Alimemazine—Gynaecomastia—Methotrexate—breast cancer	0.000175	0.00232	CcSEcCtD
Alimemazine—Atrioventricular block—Doxorubicin—breast cancer	0.000175	0.00231	CcSEcCtD
Alimemazine—Orthostatic hypotension—Capecitabine—breast cancer	0.000175	0.00231	CcSEcCtD
Alimemazine—Rash—Idarubicin—breast cancer	0.000174	0.0023	CcSEcCtD
Alimemazine—Rash—Raloxifene—breast cancer	0.000174	0.0023	CcSEcCtD
Alimemazine—Hypokalaemia—Capecitabine—breast cancer	0.000174	0.0023	CcSEcCtD
Alimemazine—Dermatitis—Raloxifene—breast cancer	0.000174	0.0023	CcSEcCtD
Alimemazine—Dermatitis—Idarubicin—breast cancer	0.000174	0.0023	CcSEcCtD
Alimemazine—Convulsion—Thiotepa—breast cancer	0.000173	0.00228	CcSEcCtD
Alimemazine—Arrhythmia—Gemcitabine—breast cancer	0.000172	0.00227	CcSEcCtD
Alimemazine—Insomnia—Goserelin—breast cancer	0.000172	0.00227	CcSEcCtD
Alimemazine—Ventricular tachycardia—Doxorubicin—breast cancer	0.00017	0.00224	CcSEcCtD
Alimemazine—Infection—Vinorelbine—breast cancer	0.000169	0.00223	CcSEcCtD
Alimemazine—Arrhythmia—Fluorouracil—breast cancer	0.000169	0.00223	CcSEcCtD
Alimemazine—Nervous system disorder—Vinorelbine—breast cancer	0.000167	0.0022	CcSEcCtD
Alimemazine—Photosensitivity—Methotrexate—breast cancer	0.000162	0.00214	CcSEcCtD
Alimemazine—Infection—Thiotepa—breast cancer	0.000162	0.00213	CcSEcCtD
Alimemazine—Nervous system disorder—Thiotepa—breast cancer	0.000159	0.00211	CcSEcCtD
Alimemazine—Hypotension—Vinorelbine—breast cancer	0.000159	0.0021	CcSEcCtD
Alimemazine—Photosensitivity—Epirubicin—breast cancer	0.000152	0.002	CcSEcCtD
Alimemazine—Photosensitivity reaction—Capecitabine—breast cancer	0.000151	0.00199	CcSEcCtD
Alimemazine—Body temperature increased—Goserelin—breast cancer	0.00015	0.00198	CcSEcCtD
Alimemazine—Cardiac disorder—Paclitaxel—breast cancer	0.00015	0.00198	CcSEcCtD
Alimemazine—Convulsion—Mitoxantrone—breast cancer	0.000149	0.00197	CcSEcCtD
Alimemazine—Jaundice—Docetaxel—breast cancer	0.000148	0.00196	CcSEcCtD
Alimemazine—Arrhythmia—Paclitaxel—breast cancer	0.000144	0.0019	CcSEcCtD
Alimemazine—Jaundice—Capecitabine—breast cancer	0.000144	0.0019	CcSEcCtD
Alimemazine—Convulsion—Fluorouracil—breast cancer	0.000143	0.00189	CcSEcCtD
Alimemazine—Agranulocytosis—Docetaxel—breast cancer	0.000142	0.00188	CcSEcCtD
Alimemazine—Photosensitivity—Doxorubicin—breast cancer	0.00014	0.00185	CcSEcCtD
Alimemazine—Infection—Mitoxantrone—breast cancer	0.00014	0.00184	CcSEcCtD
Alimemazine—Infection—Irinotecan—breast cancer	0.00014	0.00184	CcSEcCtD
Alimemazine—Nervous system disorder—Irinotecan—breast cancer	0.000138	0.00182	CcSEcCtD
Alimemazine—Agranulocytosis—Capecitabine—breast cancer	0.000138	0.00182	CcSEcCtD
Alimemazine—Infection—Gemcitabine—breast cancer	0.000136	0.00179	CcSEcCtD
Alimemazine—Body temperature increased—Vinorelbine—breast cancer	0.000135	0.00178	CcSEcCtD
Alimemazine—Nervous system disorder—Gemcitabine—breast cancer	0.000134	0.00177	CcSEcCtD
Alimemazine—Infection—Fluorouracil—breast cancer	0.000134	0.00176	CcSEcCtD
Alimemazine—Nervous system disorder—Fluorouracil—breast cancer	0.000132	0.00174	CcSEcCtD
Alimemazine—Tremor—Paclitaxel—breast cancer	0.000131	0.00174	CcSEcCtD
Alimemazine—Hypotension—Irinotecan—breast cancer	0.000131	0.00173	CcSEcCtD
Alimemazine—Hypotension—Mitoxantrone—breast cancer	0.000131	0.00173	CcSEcCtD
Alimemazine—Agitation—Paclitaxel—breast cancer	0.000129	0.0017	CcSEcCtD
Alimemazine—Body temperature increased—Thiotepa—breast cancer	0.000129	0.0017	CcSEcCtD
Alimemazine—Hypotension—Gemcitabine—breast cancer	0.000128	0.00169	CcSEcCtD
Alimemazine—Insomnia—Irinotecan—breast cancer	0.000127	0.00168	CcSEcCtD
Alimemazine—Cardiac disorder—Docetaxel—breast cancer	0.000127	0.00167	CcSEcCtD
Alimemazine—Hypotension—Fluorouracil—breast cancer	0.000126	0.00166	CcSEcCtD
Alimemazine—Rash—Tamoxifen—breast cancer	0.000126	0.00166	CcSEcCtD
Alimemazine—Dermatitis—Tamoxifen—breast cancer	0.000125	0.00166	CcSEcCtD
Alimemazine—Insomnia—Gemcitabine—breast cancer	0.000124	0.00163	CcSEcCtD
Alimemazine—Rash—Melphalan—breast cancer	0.000123	0.00162	CcSEcCtD
Alimemazine—Cardiac disorder—Capecitabine—breast cancer	0.000123	0.00162	CcSEcCtD
Alimemazine—Dermatitis—Melphalan—breast cancer	0.000123	0.00162	CcSEcCtD
Alimemazine—Arrhythmia—Docetaxel—breast cancer	0.000122	0.00161	CcSEcCtD
Alimemazine—Eosinophilia—Methotrexate—breast cancer	0.000122	0.00161	CcSEcCtD
Alimemazine—Orthostatic hypotension—Epirubicin—breast cancer	0.000122	0.00161	CcSEcCtD
Alimemazine—Insomnia—Fluorouracil—breast cancer	0.000122	0.00161	CcSEcCtD
Alimemazine—Convulsion—Paclitaxel—breast cancer	0.000122	0.00161	CcSEcCtD
Alimemazine—Hypokalaemia—Epirubicin—breast cancer	0.000121	0.0016	CcSEcCtD
Alimemazine—Rash—Goserelin—breast cancer	0.00012	0.00158	CcSEcCtD
Alimemazine—Dermatitis—Goserelin—breast cancer	0.00012	0.00158	CcSEcCtD
Alimemazine—Arrhythmia—Capecitabine—breast cancer	0.000118	0.00156	CcSEcCtD
Alimemazine—Dry mouth—Paclitaxel—breast cancer	0.000117	0.00154	CcSEcCtD
Alimemazine—Eosinophilia—Epirubicin—breast cancer	0.000114	0.00151	CcSEcCtD
Alimemazine—Infection—Paclitaxel—breast cancer	0.000114	0.0015	CcSEcCtD
Alimemazine—Erectile dysfunction—Methotrexate—breast cancer	0.000113	0.0015	CcSEcCtD
Alimemazine—Orthostatic hypotension—Doxorubicin—breast cancer	0.000113	0.00149	CcSEcCtD
Alimemazine—Nervous system disorder—Paclitaxel—breast cancer	0.000112	0.00148	CcSEcCtD
Alimemazine—Photosensitivity reaction—Methotrexate—breast cancer	0.000112	0.00148	CcSEcCtD
Alimemazine—Hypokalaemia—Doxorubicin—breast cancer	0.000112	0.00148	CcSEcCtD
Alimemazine—Body temperature increased—Irinotecan—breast cancer	0.000111	0.00147	CcSEcCtD
Alimemazine—Body temperature increased—Mitoxantrone—breast cancer	0.000111	0.00147	CcSEcCtD
Alimemazine—Ethopropazine—BCHE—breast cancer	0.000111	0.0339	CrCbGaD
Alimemazine—Body temperature increased—Gemcitabine—breast cancer	0.000108	0.00143	CcSEcCtD
Alimemazine—Tremor—Capecitabine—breast cancer	0.000108	0.00142	CcSEcCtD
Alimemazine—Rash—Vinorelbine—breast cancer	0.000107	0.00142	CcSEcCtD
Alimemazine—Dermatitis—Vinorelbine—breast cancer	0.000107	0.00142	CcSEcCtD
Alimemazine—Hypotension—Paclitaxel—breast cancer	0.000107	0.00141	CcSEcCtD
Alimemazine—Body temperature increased—Fluorouracil—breast cancer	0.000106	0.0014	CcSEcCtD
Alimemazine—Eosinophilia—Doxorubicin—breast cancer	0.000105	0.00139	CcSEcCtD
Alimemazine—Photosensitivity reaction—Epirubicin—breast cancer	0.000105	0.00139	CcSEcCtD
Alimemazine—Insomnia—Paclitaxel—breast cancer	0.000104	0.00137	CcSEcCtD
Alimemazine—Convulsion—Docetaxel—breast cancer	0.000103	0.00136	CcSEcCtD
Alimemazine—Rash—Thiotepa—breast cancer	0.000103	0.00135	CcSEcCtD
Alimemazine—Dermatitis—Thiotepa—breast cancer	0.000102	0.00135	CcSEcCtD
Alimemazine—Agranulocytosis—Methotrexate—breast cancer	0.000102	0.00135	CcSEcCtD
Alimemazine—Jaundice—Epirubicin—breast cancer	0.0001	0.00132	CcSEcCtD
Alimemazine—Dry mouth—Docetaxel—breast cancer	9.9e-05	0.00131	CcSEcCtD
Alimemazine—Orphenadrine—SCN10A—breast cancer	9.74e-05	0.0298	CrCbGaD
Alimemazine—Photosensitivity reaction—Doxorubicin—breast cancer	9.72e-05	0.00128	CcSEcCtD
Alimemazine—Infection—Docetaxel—breast cancer	9.64e-05	0.00127	CcSEcCtD
Alimemazine—Dry mouth—Capecitabine—breast cancer	9.59e-05	0.00127	CcSEcCtD
Alimemazine—Agranulocytosis—Epirubicin—breast cancer	9.58e-05	0.00127	CcSEcCtD
Alimemazine—Nervous system disorder—Docetaxel—breast cancer	9.52e-05	0.00126	CcSEcCtD
Alimemazine—Infection—Capecitabine—breast cancer	9.34e-05	0.00123	CcSEcCtD
Alimemazine—Clomipramine—GSTP1—breast cancer	9.3e-05	0.0284	CrCbGaD
Alimemazine—Jaundice—Doxorubicin—breast cancer	9.26e-05	0.00122	CcSEcCtD
Alimemazine—Nervous system disorder—Capecitabine—breast cancer	9.22e-05	0.00122	CcSEcCtD
Alimemazine—Cardiac disorder—Methotrexate—breast cancer	9.14e-05	0.00121	CcSEcCtD
Alimemazine—Triflupromazine—BCHE—breast cancer	9.08e-05	0.0277	CrCbGaD
Alimemazine—Hypotension—Docetaxel—breast cancer	9.07e-05	0.0012	CcSEcCtD
Alimemazine—Body temperature increased—Paclitaxel—breast cancer	9.05e-05	0.0012	CcSEcCtD
Alimemazine—Agranulocytosis—Doxorubicin—breast cancer	8.86e-05	0.00117	CcSEcCtD
Alimemazine—Rash—Irinotecan—breast cancer	8.85e-05	0.00117	CcSEcCtD
Alimemazine—Rash—Mitoxantrone—breast cancer	8.85e-05	0.00117	CcSEcCtD
Alimemazine—Dermatitis—Mitoxantrone—breast cancer	8.85e-05	0.00117	CcSEcCtD
Alimemazine—Dermatitis—Irinotecan—breast cancer	8.85e-05	0.00117	CcSEcCtD
Alimemazine—Hypotension—Capecitabine—breast cancer	8.78e-05	0.00116	CcSEcCtD
Alimemazine—Insomnia—Docetaxel—breast cancer	8.78e-05	0.00116	CcSEcCtD
Alimemazine—Rash—Gemcitabine—breast cancer	8.63e-05	0.00114	CcSEcCtD
Alimemazine—Dermatitis—Gemcitabine—breast cancer	8.62e-05	0.00114	CcSEcCtD
Alimemazine—Cardiac disorder—Epirubicin—breast cancer	8.55e-05	0.00113	CcSEcCtD
Alimemazine—Insomnia—Capecitabine—breast cancer	8.5e-05	0.00112	CcSEcCtD
Alimemazine—Rash—Fluorouracil—breast cancer	8.48e-05	0.00112	CcSEcCtD
Alimemazine—Dermatitis—Fluorouracil—breast cancer	8.47e-05	0.00112	CcSEcCtD
Alimemazine—Arrhythmia—Epirubicin—breast cancer	8.23e-05	0.00109	CcSEcCtD
Alimemazine—Cardiac disorder—Doxorubicin—breast cancer	7.91e-05	0.00104	CcSEcCtD
Alimemazine—Body temperature increased—Docetaxel—breast cancer	7.67e-05	0.00101	CcSEcCtD
Alimemazine—Arrhythmia—Doxorubicin—breast cancer	7.62e-05	0.00101	CcSEcCtD
Alimemazine—Body temperature increased—Capecitabine—breast cancer	7.43e-05	0.000981	CcSEcCtD
Alimemazine—Convulsion—Methotrexate—breast cancer	7.43e-05	0.000981	CcSEcCtD
Alimemazine—Agitation—Epirubicin—breast cancer	7.37e-05	0.000973	CcSEcCtD
Alimemazine—Rash—Paclitaxel—breast cancer	7.22e-05	0.000953	CcSEcCtD
Alimemazine—Dermatitis—Paclitaxel—breast cancer	7.21e-05	0.000953	CcSEcCtD
Alimemazine—Convulsion—Epirubicin—breast cancer	6.95e-05	0.000918	CcSEcCtD
Alimemazine—Infection—Methotrexate—breast cancer	6.95e-05	0.000918	CcSEcCtD
Alimemazine—Nervous system disorder—Methotrexate—breast cancer	6.86e-05	0.000906	CcSEcCtD
Alimemazine—Agitation—Doxorubicin—breast cancer	6.82e-05	0.000901	CcSEcCtD
Alimemazine—Dry mouth—Epirubicin—breast cancer	6.68e-05	0.000882	CcSEcCtD
Alimemazine—Cyclobenzaprine—CYP2D6—breast cancer	6.67e-05	0.0204	CrCbGaD
Alimemazine—Hypotension—Methotrexate—breast cancer	6.54e-05	0.000863	CcSEcCtD
Alimemazine—Infection—Epirubicin—breast cancer	6.51e-05	0.000859	CcSEcCtD
Alimemazine—Convulsion—Doxorubicin—breast cancer	6.43e-05	0.000849	CcSEcCtD
Alimemazine—Nervous system disorder—Epirubicin—breast cancer	6.42e-05	0.000848	CcSEcCtD
Alimemazine—Insomnia—Methotrexate—breast cancer	6.33e-05	0.000836	CcSEcCtD
Alimemazine—Mequitazine—CYP2D6—breast cancer	6.23e-05	0.019	CrCbGaD
Alimemazine—Dry mouth—Doxorubicin—breast cancer	6.18e-05	0.000816	CcSEcCtD
Alimemazine—Rash—Docetaxel—breast cancer	6.12e-05	0.000808	CcSEcCtD
Alimemazine—Hypotension—Epirubicin—breast cancer	6.12e-05	0.000808	CcSEcCtD
Alimemazine—Dermatitis—Docetaxel—breast cancer	6.12e-05	0.000807	CcSEcCtD
Alimemazine—Infection—Doxorubicin—breast cancer	6.02e-05	0.000795	CcSEcCtD
Alimemazine—Nervous system disorder—Doxorubicin—breast cancer	5.94e-05	0.000785	CcSEcCtD
Alimemazine—Rash—Capecitabine—breast cancer	5.93e-05	0.000782	CcSEcCtD
Alimemazine—Insomnia—Epirubicin—breast cancer	5.92e-05	0.000782	CcSEcCtD
Alimemazine—Dermatitis—Capecitabine—breast cancer	5.92e-05	0.000782	CcSEcCtD
Alimemazine—Cyclobenzaprine—CYP3A4—breast cancer	5.72e-05	0.0175	CrCbGaD
Alimemazine—Hypotension—Doxorubicin—breast cancer	5.66e-05	0.000748	CcSEcCtD
Alimemazine—Diltiazem—CYP2D6—breast cancer	5.59e-05	0.0171	CrCbGaD
Alimemazine—Methadone—CYP19A1—breast cancer	5.58e-05	0.0171	CrCbGaD
Alimemazine—Body temperature increased—Methotrexate—breast cancer	5.53e-05	0.00073	CcSEcCtD
Alimemazine—Insomnia—Doxorubicin—breast cancer	5.48e-05	0.000724	CcSEcCtD
Alimemazine—Mequitazine—CYP3A4—breast cancer	5.34e-05	0.0163	CrCbGaD
Alimemazine—Oxcarbazepine—CYP3A4—breast cancer	5.23e-05	0.016	CrCbGaD
Alimemazine—Body temperature increased—Epirubicin—breast cancer	5.18e-05	0.000683	CcSEcCtD
Alimemazine—Diltiazem—CYP3A4—breast cancer	4.79e-05	0.0146	CrCbGaD
Alimemazine—Body temperature increased—Doxorubicin—breast cancer	4.79e-05	0.000632	CcSEcCtD
Alimemazine—Diphenhydramine—PTGS1—breast cancer	4.65e-05	0.0142	CrCbGaD
Alimemazine—Oxcarbazepine—ALB—breast cancer	4.56e-05	0.0139	CrCbGaD
Alimemazine—Dextropropoxyphene—CYP2D6—breast cancer	4.5e-05	0.0138	CrCbGaD
Alimemazine—Pipotiazine—CYP2D6—breast cancer	4.43e-05	0.0135	CrCbGaD
Alimemazine—Rash—Methotrexate—breast cancer	4.41e-05	0.000582	CcSEcCtD
Alimemazine—Dermatitis—Methotrexate—breast cancer	4.41e-05	0.000582	CcSEcCtD
Alimemazine—Chlorpromazine—BCHE—breast cancer	4.38e-05	0.0134	CrCbGaD
Alimemazine—Mesoridazine—CYP2D6—breast cancer	4.37e-05	0.0134	CrCbGaD
Alimemazine—Prochlorperazine—CYP2D6—breast cancer	4.24e-05	0.0129	CrCbGaD
Alimemazine—Rash—Epirubicin—breast cancer	4.13e-05	0.000545	CcSEcCtD
Alimemazine—Dermatitis—Epirubicin—breast cancer	4.12e-05	0.000545	CcSEcCtD
Alimemazine—Diltiazem—ABCB1—breast cancer	3.99e-05	0.0122	CrCbGaD
Alimemazine—Dextropropoxyphene—CYP3A4—breast cancer	3.86e-05	0.0118	CrCbGaD
Alimemazine—Rash—Doxorubicin—breast cancer	3.82e-05	0.000504	CcSEcCtD
Alimemazine—Dermatitis—Doxorubicin—breast cancer	3.82e-05	0.000504	CcSEcCtD
Alimemazine—Pipotiazine—CYP3A4—breast cancer	3.8e-05	0.0116	CrCbGaD
Alimemazine—Prochlorperazine—CYP3A4—breast cancer	3.63e-05	0.0111	CrCbGaD
Alimemazine—Carbamazepine—CYP3A4—breast cancer	3.57e-05	0.0109	CrCbGaD
Alimemazine—Triflupromazine—ABCB1—breast cancer	3.56e-05	0.0109	CrCbGaD
Alimemazine—Clomipramine—CYP2D6—breast cancer	3.5e-05	0.0107	CrCbGaD
Alimemazine—Acepromazine—ALB—breast cancer	3.45e-05	0.0105	CrCbGaD
Alimemazine—Benzphetamine—CYP3A4—breast cancer	3.39e-05	0.0104	CrCbGaD
Alimemazine—Thioproperazine—ALB—breast cancer	3.37e-05	0.0103	CrCbGaD
Alimemazine—Pipotiazine—ALB—breast cancer	3.32e-05	0.0101	CrCbGaD
Alimemazine—Thioridazine—CYP2D6—breast cancer	3.3e-05	0.0101	CrCbGaD
Alimemazine—Trimipramine—CYP2D6—breast cancer	3.22e-05	0.00985	CrCbGaD
Alimemazine—Diphenhydramine—CYP2D6—breast cancer	3.17e-05	0.00967	CrCbGaD
Alimemazine—Methotrimeprazine—CYP2D6—breast cancer	3.15e-05	0.00963	CrCbGaD
Alimemazine—Promethazine—CYP2D6—breast cancer	3.1e-05	0.00948	CrCbGaD
Alimemazine—Doxepin—CYP2D6—breast cancer	3.07e-05	0.00939	CrCbGaD
Alimemazine—Methadone—CYP2D6—breast cancer	3.06e-05	0.00934	CrCbGaD
Alimemazine—Perphenazine—CYP2D6—breast cancer	3.03e-05	0.00925	CrCbGaD
Alimemazine—Clomipramine—CYP3A4—breast cancer	3e-05	0.00918	CrCbGaD
Alimemazine—Carbamazepine—ABCB1—breast cancer	2.97e-05	0.00907	CrCbGaD
Alimemazine—Desipramine—CYP2D6—breast cancer	2.82e-05	0.00861	CrCbGaD
Alimemazine—Trimipramine—CYP3A4—breast cancer	2.76e-05	0.00845	CrCbGaD
Alimemazine—Doxepin—CYP3A4—breast cancer	2.63e-05	0.00805	CrCbGaD
Alimemazine—Clomipramine—ALB—breast cancer	2.62e-05	0.00801	CrCbGaD
Alimemazine—Methadone—CYP3A4—breast cancer	2.62e-05	0.00801	CrCbGaD
Alimemazine—Perphenazine—CYP3A4—breast cancer	2.6e-05	0.00794	CrCbGaD
Alimemazine—Orphenadrine—CYP3A4—breast cancer	2.57e-05	0.00785	CrCbGaD
Alimemazine—Clomipramine—ABCB1—breast cancer	2.5e-05	0.00764	CrCbGaD
Alimemazine—Chlorprothixene—ABCB1—breast cancer	2.49e-05	0.00761	CrCbGaD
Alimemazine—Desipramine—CYP3A4—breast cancer	2.42e-05	0.00739	CrCbGaD
Alimemazine—Chlorpromazine—CYP2D6—breast cancer	2.4e-05	0.00734	CrCbGaD
Alimemazine—Imipramine—CYP2D6—breast cancer	2.39e-05	0.0073	CrCbGaD
Alimemazine—Amitriptyline—CYP2D6—breast cancer	2.38e-05	0.00726	CrCbGaD
Alimemazine—Promazine—CYP3A4—breast cancer	2.34e-05	0.00716	CrCbGaD
Alimemazine—Trimipramine—ABCB1—breast cancer	2.3e-05	0.00703	CrCbGaD
Alimemazine—Promethazine—ABCB1—breast cancer	2.22e-05	0.00677	CrCbGaD
Alimemazine—Doxepin—ABCB1—breast cancer	2.19e-05	0.0067	CrCbGaD
Alimemazine—Trifluoperazine—ABCB1—breast cancer	2.19e-05	0.00668	CrCbGaD
Alimemazine—Methadone—ABCB1—breast cancer	2.18e-05	0.00667	CrCbGaD
Alimemazine—Chlorpromazine—CYP3A4—breast cancer	2.06e-05	0.0063	CrCbGaD
Alimemazine—Imipramine—CYP3A4—breast cancer	2.05e-05	0.00626	CrCbGaD
Alimemazine—Amitriptyline—CYP3A4—breast cancer	2.04e-05	0.00623	CrCbGaD
Alimemazine—Desipramine—ABCB1—breast cancer	2.01e-05	0.00615	CrCbGaD
Alimemazine—Chlorpromazine—ALB—breast cancer	1.8e-05	0.00549	CrCbGaD
Alimemazine—Amitriptyline—ALB—breast cancer	1.78e-05	0.00543	CrCbGaD
Alimemazine—Chlorpromazine—ABCB1—breast cancer	1.72e-05	0.00524	CrCbGaD
Alimemazine—Imipramine—ABCB1—breast cancer	1.71e-05	0.00522	CrCbGaD
Alimemazine—Amitriptyline—ABCB1—breast cancer	1.7e-05	0.00518	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	5.37e-06	0.000925	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VCP—breast cancer	5.2e-06	0.000896	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GLI2—breast cancer	5.2e-06	0.000896	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	5.17e-06	0.000892	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LEPR—breast cancer	5.12e-06	0.000882	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	5.11e-06	0.00088	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CALCA—breast cancer	5e-06	0.000861	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	4.96e-06	0.000854	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CXCL12—breast cancer	4.88e-06	0.000841	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CXCR4—breast cancer	4.88e-06	0.000841	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AGTR1—breast cancer	4.86e-06	0.000837	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	4.82e-06	0.000831	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ARHGDIA—breast cancer	4.76e-06	0.00082	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FST—breast cancer	4.64e-06	0.000799	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HEY2—breast cancer	4.58e-06	0.000789	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SYNJ2—breast cancer	4.53e-06	0.00078	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RPS6KB2—breast cancer	4.53e-06	0.00078	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RGS2—breast cancer	4.47e-06	0.000771	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	4.43e-06	0.000764	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCL20—breast cancer	4.42e-06	0.000762	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AGTR1—breast cancer	4.41e-06	0.00076	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ITPR1—breast cancer	4.36e-06	0.000751	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TLE3—breast cancer	4.28e-06	0.000738	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LPAR1—breast cancer	4.28e-06	0.000738	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HEY1—breast cancer	4.24e-06	0.000731	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NDUFS3—breast cancer	4.21e-06	0.000725	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DLL1—breast cancer	4.16e-06	0.000717	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	4.1e-06	0.000707	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	4.08e-06	0.000703	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	4.08e-06	0.000703	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRB7—breast cancer	4.05e-06	0.000697	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PDE4D—breast cancer	4.05e-06	0.000697	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CSF2—breast cancer	4.03e-06	0.000694	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TAB2—breast cancer	3.98e-06	0.000685	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ITPR1—breast cancer	3.96e-06	0.000682	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CHST9—breast cancer	3.96e-06	0.000682	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CNR2—breast cancer	3.94e-06	0.000679	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—CXCL8—breast cancer	3.94e-06	0.000679	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MMP3—breast cancer	3.93e-06	0.000678	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	3.92e-06	0.000676	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DKK1—breast cancer	3.85e-06	0.000663	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VEGFC—breast cancer	3.82e-06	0.000658	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JAG2—breast cancer	3.76e-06	0.000648	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—COX11—breast cancer	3.75e-06	0.000646	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—WNT1—breast cancer	3.71e-06	0.000639	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	3.7e-06	0.000637	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CSF2—breast cancer	3.66e-06	0.00063	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOTCH4—breast cancer	3.51e-06	0.000605	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GZMB—breast cancer	3.49e-06	0.000602	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SHMT1—breast cancer	3.43e-06	0.000591	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CDA—breast cancer	3.43e-06	0.000591	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCL2—breast cancer	3.39e-06	0.000584	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AGTR2—breast cancer	3.39e-06	0.000584	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTHLH—breast cancer	3.35e-06	0.000578	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—BMP2—breast cancer	3.35e-06	0.000578	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLCO1B1—breast cancer	3.3e-06	0.000569	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC2A5—breast cancer	3.3e-06	0.000569	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EDNRB—breast cancer	3.25e-06	0.000559	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PGR—breast cancer	3.21e-06	0.000554	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—THBS1—breast cancer	3.2e-06	0.000551	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—APRT—breast cancer	3.19e-06	0.000549	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FLT1—breast cancer	3.05e-06	0.000526	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SQSTM1—breast cancer	3.04e-06	0.000524	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF3—breast cancer	3.04e-06	0.000524	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	3.02e-06	0.000521	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JAG1—breast cancer	3e-06	0.000517	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ESRRA—breast cancer	3e-06	0.000517	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ANGPTL4—breast cancer	3e-06	0.000517	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PARP1—breast cancer	2.99e-06	0.000515	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOTCH3—breast cancer	2.99e-06	0.000515	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CALCA—breast cancer	2.95e-06	0.000509	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RPS6—breast cancer	2.92e-06	0.000502	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF4—breast cancer	2.89e-06	0.000499	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCL12—breast cancer	2.88e-06	0.000497	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCR4—breast cancer	2.88e-06	0.000497	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HADHB—breast cancer	2.84e-06	0.00049	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPI—breast cancer	2.84e-06	0.00049	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PAK1—breast cancer	2.83e-06	0.000488	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TCF7L2—breast cancer	2.78e-06	0.000479	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AKT2—breast cancer	2.77e-06	0.000477	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	2.75e-06	0.000473	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.71e-06	0.000467	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.71e-06	0.000467	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOTCH2—breast cancer	2.68e-06	0.000462	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	2.68e-06	0.000462	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	2.66e-06	0.000458	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PRL—breast cancer	2.61e-06	0.000449	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AGTR1—breast cancer	2.61e-06	0.000449	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PHGDH—breast cancer	2.6e-06	0.000448	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ADSL—breast cancer	2.6e-06	0.000448	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UMPS—breast cancer	2.6e-06	0.000448	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—FHL2—breast cancer	2.6e-06	0.000448	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NME1—breast cancer	2.6e-06	0.000448	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADAM10—breast cancer	2.57e-06	0.000443	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—STK11—breast cancer	2.57e-06	0.000443	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HPSE—breast cancer	2.55e-06	0.000439	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—BRIP1—breast cancer	2.55e-06	0.000439	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LDHB—breast cancer	2.55e-06	0.000439	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PLG—breast cancer	2.54e-06	0.000438	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AKT2—breast cancer	2.51e-06	0.000433	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF10—breast cancer	2.5e-06	0.000431	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCC1—breast cancer	2.42e-06	0.000416	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HMMR—breast cancer	2.42e-06	0.000416	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA3—breast cancer	2.42e-06	0.000416	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	2.41e-06	0.000416	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PDGFA—breast cancer	2.41e-06	0.000416	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFBR2—breast cancer	2.38e-06	0.00041	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.34e-06	0.000403	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ITPR1—breast cancer	2.34e-06	0.000403	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB4—breast cancer	2.32e-06	0.0004	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—STAT5A—breast cancer	2.32e-06	0.0004	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MMP3—breast cancer	2.32e-06	0.0004	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	2.32e-06	0.000399	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SMAD4—breast cancer	2.25e-06	0.000388	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1R—breast cancer	2.24e-06	0.000385	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	2.23e-06	0.000384	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA4—breast cancer	2.21e-06	0.000381	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CA9—breast cancer	2.21e-06	0.000381	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HES1—breast cancer	2.2e-06	0.000379	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NCOR1—breast cancer	2.18e-06	0.000376	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	2.18e-06	0.000376	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CSF2—breast cancer	2.16e-06	0.000372	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF1—breast cancer	2.16e-06	0.000372	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—RAF1—breast cancer	2.16e-06	0.000371	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA2—breast cancer	2.15e-06	0.000371	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPX2—breast cancer	2.15e-06	0.000371	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NRG1—breast cancer	2.14e-06	0.000369	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—H2AFX—breast cancer	2.13e-06	0.000367	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—IL2—breast cancer	2.13e-06	0.000367	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPX4—breast cancer	2.13e-06	0.000367	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SULT1A1—breast cancer	2.13e-06	0.000367	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—E2F1—breast cancer	2.11e-06	0.000364	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	2.1e-06	0.000363	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—IDH1—breast cancer	2.08e-06	0.000358	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA1—breast cancer	2.08e-06	0.000358	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NAT2—breast cancer	2.05e-06	0.000354	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SPP1—breast cancer	2.03e-06	0.00035	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CXCL8—breast cancer	2.02e-06	0.000348	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB3—breast cancer	2.01e-06	0.000346	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGFR2—breast cancer	2.01e-06	0.000346	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL2—breast cancer	1.93e-06	0.000333	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TERT—breast cancer	1.93e-06	0.000332	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGFR1—breast cancer	1.87e-06	0.000322	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIF1A—breast cancer	1.84e-06	0.000317	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—DPYD—breast cancer	1.8e-06	0.00031	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MED12—breast cancer	1.8e-06	0.00031	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LEP—breast cancer	1.8e-06	0.00031	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CAV1—breast cancer	1.78e-06	0.000307	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALDOA—breast cancer	1.77e-06	0.000306	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KDR—breast cancer	1.76e-06	0.000303	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA3—breast cancer	1.72e-06	0.000297	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ESR1—breast cancer	1.72e-06	0.000296	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC2A2—breast cancer	1.71e-06	0.000295	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FN1—breast cancer	1.69e-06	0.000292	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CPT1A—breast cancer	1.67e-06	0.000289	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCG2—breast cancer	1.67e-06	0.000289	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTR—breast cancer	1.67e-06	0.000289	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NFKBIA—breast cancer	1.67e-06	0.000289	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOTCH1—breast cancer	1.66e-06	0.000286	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HPGDS—breast cancer	1.64e-06	0.000283	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HBA1—breast cancer	1.63e-06	0.000281	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KIT—breast cancer	1.62e-06	0.00028	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CG—breast cancer	1.62e-06	0.00028	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APC—breast cancer	1.62e-06	0.00028	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGF—breast cancer	1.6e-06	0.000276	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ACHE—breast cancer	1.59e-06	0.000275	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTT1—breast cancer	1.59e-06	0.000275	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MAPK3—breast cancer	1.55e-06	0.000268	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—BRAF—breast cancer	1.52e-06	0.000263	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.51e-06	0.00026	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ENO1—breast cancer	1.49e-06	0.000257	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTGS1—breast cancer	1.49e-06	0.000257	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1—breast cancer	1.49e-06	0.000256	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKT2—breast cancer	1.48e-06	0.000256	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EGFR—breast cancer	1.48e-06	0.000255	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.46e-06	0.000252	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA2—breast cancer	1.44e-06	0.000248	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CD—breast cancer	1.43e-06	0.000246	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	1.41e-06	0.000243	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SERPINE1—breast cancer	1.41e-06	0.000243	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—KRAS—breast cancer	1.4e-06	0.000241	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—FASN—breast cancer	1.39e-06	0.00024	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—BCHE—breast cancer	1.39e-06	0.000239	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.37e-06	0.000236	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOS3—breast cancer	1.35e-06	0.000232	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.32e-06	0.000228	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NQO1—breast cancer	1.32e-06	0.000228	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	1.28e-06	0.000221	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MDM2—breast cancer	1.28e-06	0.00022	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RAF1—breast cancer	1.27e-06	0.000219	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.27e-06	0.000219	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RELA—breast cancer	1.27e-06	0.000218	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB2—breast cancer	1.26e-06	0.000217	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.24e-06	0.000215	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MTOR—breast cancer	1.24e-06	0.000214	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CB—breast cancer	1.24e-06	0.000214	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA1—breast cancer	1.21e-06	0.000209	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCL8—breast cancer	1.19e-06	0.000206	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—STK11—breast cancer	1.19e-06	0.000206	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.19e-06	0.000206	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HRAS—breast cancer	1.19e-06	0.000204	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.17e-06	0.000201	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.15e-06	0.000199	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CASP3—breast cancer	1.14e-06	0.000197	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL2—breast cancer	1.14e-06	0.000197	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL6—breast cancer	1.14e-06	0.000196	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCND1—breast cancer	1.11e-06	0.000192	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JUN—breast cancer	1.11e-06	0.000191	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—COMT—breast cancer	1.11e-06	0.000191	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTP1—breast cancer	1.1e-06	0.00019	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.1e-06	0.00019	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HMOX1—breast cancer	1.09e-06	0.000188	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ITPR1—breast cancer	1.09e-06	0.000187	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MMP9—breast cancer	1.08e-06	0.000186	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.08e-06	0.000185	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTEN—breast cancer	1.07e-06	0.000185	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.05e-06	0.000181	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.05e-06	0.000181	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCB1—breast cancer	1.05e-06	0.00018	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TYMS—breast cancer	1.03e-06	0.000177	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.01e-06	0.000175	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM1—breast cancer	1.01e-06	0.000175	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOR1—breast cancer	1.01e-06	0.000175	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SRC—breast cancer	9.96e-07	0.000172	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPX1—breast cancer	9.72e-07	0.000167	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VEGFA—breast cancer	9.7e-07	0.000167	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.62e-07	0.000166	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—STAT3—breast cancer	9.61e-07	0.000166	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ERCC2—breast cancer	9.54e-07	0.000164	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAPK3—breast cancer	9.18e-07	0.000158	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTHFR—breast cancer	8.97e-07	0.000155	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MYC—breast cancer	8.93e-07	0.000154	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFB1—breast cancer	8.9e-07	0.000153	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGFR—breast cancer	8.73e-07	0.00015	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CAV1—breast cancer	8.27e-07	0.000143	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KRAS—breast cancer	8.25e-07	0.000142	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.58e-07	0.000131	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.54e-07	0.00013	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TP53—breast cancer	7.33e-07	0.000126	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HRAS—breast cancer	7.01e-07	0.000121	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL6—breast cancer	6.71e-07	0.000116	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.62e-07	0.000114	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ALB—breast cancer	6.54e-07	0.000113	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NOS3—breast cancer	6.26e-07	0.000108	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKT1—breast cancer	6.19e-07	0.000107	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.77e-07	9.95e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTGS2—breast cancer	5.72e-07	9.86e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTEN—breast cancer	4.99e-07	8.6e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.52e-07	6.06e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AKT1—breast cancer	2.88e-07	4.95e-05	CbGpPWpGaD
